Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Incyte Aktie: Neuer Hoffnungsträger in der Pipeline?


Das Biotech-Unternehmen Incyte könnte einen entscheidenden Schub für seine Dermatologie-Sparte erhalten. Neue Langzeitdaten des…

Der Beitrag Incyte Aktie: Neuer Hoffnungsträger in der Pipeline? erschien zuerst auf kapitalmarktexperten.de.


Quelle kapitalmarktexperten.de

Incyte Corp. Stock

€88.06
3.060%
Incyte Corp. dominated the market today, gaining €2.64 (3.060%).
With 14 Buy predictions and only 1 Sell predictions the community sentiment for the stock is positive.
As a result the target price of 90 € shows a slightly positive potential of 2.2% compared to the current price of 88.06 € for Incyte Corp..

Comments